Clinical Trials Logo

Filter by:
NCT ID: NCT03956732 Not yet recruiting - Appetite Regulation Clinical Trials

Effects of Milk Protein and Vitamin D on Children's Growth and Health

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

The purpose of D-pro is to investigate the combined and separate effects of milk protein and vitamin D on bone health, growth, muscle function, body composition and cardiometabolic health in 6-8-year-old children.

NCT ID: NCT03956173 Active, not recruiting - Hypoglycemia Clinical Trials

Hypoglycemia and Cardiac Arrhythmias in Type 1 Diabetes

Start date: December 1, 2018
Study type: Observational

The investigators hypothesise that patients with type 1 diabetes have clinically relevant, but often unrecognised, episodes of arrhythmias linked to episodes of hypoglycaemia and/or clinically significant fluctuations in plasma glucose. Furthermore, the investigators hypothesise that following episodes of hypoglycaemia, rebound hyperglycaemia may result in a prolonged period of increased QTc and, thereby, increased susceptibility to serious cardiac arrhythmias.

NCT ID: NCT03955575 Recruiting - Clinical trials for Bile Acid Malabsorption

Treatment of Bile Acid Malabsorption With Liraglutide

Start date: March 7, 2019
Phase: Phase 4
Study type: Interventional

Comparing the effect of Liraglutide on bile acid malabsorption, with colesevelam

NCT ID: NCT03955081 Not yet recruiting - Clinical trials for Safety and Performance

A Clinical Study With the Medical Device PowerSpiral for Deep Enteroscopy

Start date: May 2019
Study type: Observational [Patient Registry]

The objective of the SAMISEN study is to assess the performance and safety of diagnostic and therapeutic procedures with the newly designed Olympus Motorized Spiral Enteroscope (PowerSpiral).

NCT ID: NCT03954873 Active, not recruiting - Clinical trials for Glucose Metabolism Disorders

Glucagon-like Peptide 2 - a Glucose Dependent Glucagonotropic Hormone?

Start date: January 31, 2019
Phase: N/A
Study type: Interventional

Infusion of glucagon-like peptide 2 (GLP-2) during euglycaemia, hypoglycaemia and hyperglycaemia and evaluation of the effect on glucagon secretion in healthy subjects.

NCT ID: NCT03954574 Recruiting - Clinical trials for Pulmonary Circulation Diseases

Pulmonary Hemodynamics During Exercise - Research Network

Start date: December 1, 2018
Study type: Observational [Patient Registry]

The purpose of this Clinical Research Collaboration is to investigate the prognostic implications of pulmonary hemodynamics during exercise based on a large scale multi-centre approach by using retrospective and prospective analysis of hemodynamic data.

NCT ID: NCT03954418 Not yet recruiting - Diabetes Clinical Trials

Transport of Artificial Sweeteners During Pregnancy

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

With obesity on the rise worldwide more and more young women are also affected, leading to a higher prevalence of obese pregnant women and pregnant women with diabetes. Children of these women are in risk of developing obesity during childhood which again leads to overweight during adult life resulting in life-style related diseases such as diabetes and cardio-vascular disease. Overweight and diabetic women are currently advised to substitute sugar sweetened beverages with artificially sweetened beverages to lower caloric intake and avoid fluctuations in blood glucose to avoid complications during pregnancy for both mother and child. Recent studies suggest that high intake of artificial sweeteners during pregnancy increases the risk of the child developing obesity. If this is indeed true, the current guidelines have the opposite of the wanted and children already in risk of overweight are exposed to extra risk. To investigate if artificial sweeteners can affect the foetus, we wish to examine whether artificial sweeteners can cross the placenta. We will do this by a clinical trial in which 40 women will be enrolled. 30 women will drink a diet soft drink 2 hours before a caesarean section and 10 controls will refrain from intake. After birth we will then obtain a blood sample from the mother and from the umbilical cord and measure the contents of artificial sweeteners. Furthermore, we will obtain a sample of amniotic fluid to examine if the sweeteners are excreted into the amniotic fluid. The results ultimately have the potential to change the current guidelines on diet for overweight and diabetic women during pregnancy.

NCT ID: NCT03953287 Not yet recruiting - Clinical trials for Pharmacological Action

Pharmacokinetic Study of Paracetamol.

Start date: August 18, 2019
Phase: Phase 1
Study type: Interventional

Brief Summary: The study evaluate the absorption rate and pharmacodynamic of different formulation of paracetamol either in the form of normal tablets or a new rapid absorbable gelation capsule formulation "Paracetamol1523" by determining T-max and area under the response curve of paracetamol in blood concentration as well as from clinical effects after intake. Data is entered on data sheet in anonymous form and processed. The results are presented in anonymous form by publication and lecture. Experts are given the supplement: "The applicant's rights in a biomedical research project

NCT ID: NCT03952858 Recruiting - Clinical trials for Frail Elderly Syndrome

Telerehabilitation in Geriatric Patients

Start date: March 1, 2018
Phase: N/A
Study type: Interventional

Background Older patients admitted to an emergency department (ED) are dependent on assistive devices and almost 16 % have no gait function. It seems appropriate to identify patients who need physical exercises immediately after discharge to avoid further functional decline. New IT technologies make it possible to both supervise the exercises and communicate with the patients via video conferencing equipment. Until now no studies have examined if the Otago Exercise Program supervised by video conferencing may enhance motivation and maintain or improve physical functional capacity in acute elderly patients. Hypothesis Early telerehabilitation performed in groups based on the Otago Exercise Program is compared with traditional exercise programs offered in the community centers in geriatric patients after hospital discharge from acute care. The study is a randomized, controlled study conducted at Aarhus University Hospital (AUH). The population is elderly patients ≥65 years, residents in the municipality of Aarhus and admitted acutely from there own home to the Emergency Department. Intervention Group will start telerehabilitation first to second week after discharge. After the initial two training sessions, the patient will be included in a telerehabilitation group. When there is a group of two to three participants the group will stop including more members in that group in order to achieve the expected benefits of group exercising. It will be possible for physiotherapists to follow the team on the screen and to communicate with the participants. In addition, the participants may communicate with each other. The following four weeks the patients will exercise on their own in their training groups on appointed times via videoconferencing equipment. The control group will receive the usual training offered by the municipality. Participants in both groups will be tested with the same instruments at baseline and after four and eight weeks and at six months. Perspective If the presented project indicates that the older target group may benefit from telerehabilitation immediately after discharge, elderly patients may increase their quality of life and the municipalities may experience public savings. Telerehabilitation may be a good alternative for patients who aren't able to receive training at the community center for physical reasons. Telerehabilitation may be one of the means to meet the challenge of the increasing proportion of elderly people in Denmark.

NCT ID: NCT03952273 Not yet recruiting - Clinical trials for Coronary Artery Disease

Sort Out XI - Combo Stent Versus BioMatrix Alpha Stent

Start date: May 30, 2019
Phase: N/A
Study type: Interventional

SORT OUT XI Comparison of Combo™ stent and BioMatrix Alpha™ stent in the treatment of unselected patients with ischemic heart disease.